Pure Global

System Accuracy of 14 Blood Glucose Monitoring Systems - Trial NCT06037499

Access comprehensive clinical trial information for NCT06037499 through Pure Global AI's free database. This phase not specified trial is sponsored by Institut fur Diabetes Karlsburg GmbH and is currently Enrolling by invitation. The study focuses on Diabetes. Target enrollment is 500 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06037499
Enrolling by invitation
diagnostic test
Trial Details
ClinicalTrials.gov • NCT06037499
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
System Accuracy of 14 Blood Glucose Monitoring Systems
Leistungsbewertungsprüfung Der Systemgenauigkeit, Von 14 Blutglukose Monitoring Systemen in Anlehnung an ISO 15197:2015

Study Focus

Diabetes

Glucometer Test

Interventional

diagnostic test

Sponsor & Location

Institut fur Diabetes Karlsburg GmbH

Karlsburg, Germany

Timeline & Enrollment

N/A

Mar 03, 2023

Mar 01, 2025

500 participants

Primary Outcome

Blood glucose measurement using BGMS

Summary

The system accuracy of 14 blood glucose monitoring systems is to be evaluated randomly in
 accordance with DIN EN ISO 15197:2015 over thr courese of 24 months

ICD-10 Classifications

Diabetes mellitus
Unspecified diabetes mellitus
Other specified diabetes mellitus
Unspecified diabetes mellitus without complications
Other specified diabetes mellitus without complications

Data Source

ClinicalTrials.gov

NCT06037499

Non-Device Trial